期刊文献+

利用DALY指标分析艾滋病的疾病负担 被引量:9

Trend Analysis of Healthy Life Years Lost of AIDS
原文传递
导出
摘要 目的:利用残疾调整生命年指标分析艾滋病的疾病负担,确定艾滋病在中国的高危人群,为制定艾滋病有效的防治措施提供数据依据,为政府合理分配有限的卫生资金提供科学佐证。方法:将我国2007年艾滋病的发病、死亡情况按照年龄、性别整理,计算艾滋病疾病负担指标中的残疾调整生命年;利用伤残调整生命年强度指标进行各年龄组、性别的比较,以控制相互比较组别人口基数的影响。结果:我国2007年艾滋病伤残调整生命年为108312.55人年,负担强度为0.0824人年/千人,由死亡造成疾病负担高达101037.40人年,占总的残疾调整生命年比例为93.28%;疾病负担主要集中在15岁至60岁年龄段,这一年龄段占总残疾调整生命年比例的93.86%,30岁至45岁是疾病负担最高的年龄组;艾滋病的疾病负担男性高于女性,男女比例接近2∶1。结论:我国人群中的30岁至45岁年龄组和男性是艾滋病防治工作的重中之重,缺乏有效的治疗手段是目前我国艾滋病疾病负担产生的主要原因。 Objective: Through the calculation of disability adjusted life years caused by AIDS in 2007, we can identify the focus of prevention and control work on AIDS and format scientific evidence to provide the rational planning of health resources distribution. Methods: Sorting incidence and mortality data by age and gender, then calculate disability adjusted life years strength index for each age group, sex, compared to comparable control Groups of the population base. Results: Disability adjusted life years caused by AIDS is 108312.55 person years in 2007, the burden of disease caused by YLL is up to 101037.4 person years, DALY of 93.28 percent; mainly in the 15 to less than 60 age group, DALY of 93.86 percent, Age Peak appear at the 30 to less than 60 age group; Disability adjusted life of the men are twice the women. Conclusion: AIDS prevention and control work should be the main focus at the 30 to less than 45 age group and male crowd, the lack of an effective treatment for AIDS is main reason resulting from the burden of disease.
出处 《中国卫生经济》 北大核心 2009年第2期52-53,共2页 Chinese Health Economics
基金 黑龙江省教育厅课题(11521143)
关键词 艾滋病 疾病负担 伤残调整生命年 AIDS burden of disease DALY
  • 相关文献

参考文献6

  • 1WHO Library cataloguing-Publication Data UNAIDS. 2007 AIDS epidemic update[EB/OL]. (2008-04-16)[2008-06-07]. http://www. unaids.org/en./Know/edge entre/HIVDate/EpiUpdate/EpiUpdArchiver.
  • 2Christopher JL. Murray, Alan D. Lopez. Global health statistics [M]. American: The Harvard School of Public Health on Behalf of the World Health Organization and the World Bank Distributed by Harvard University Press,1996:49-67.
  • 3Christopher JL. Murray, Alan D. Lopez. The Global Burden of Disease [M]. American: The Harvard School of Public Health on Behalf of the World Health Organization and the World Bank Distributed by Harvard University Press, 1996:250-255.
  • 4刘美娜,杨凤娟,樊秀娥,杨晶,陈银苹,张秋菊.艾滋病健康生命年损失情况分析[J].中国艾滋病性病,2007,13(2):104-106. 被引量:7
  • 5黄学亮,冯曼玲,孙丽静.艾滋病的治疗现状[J].河北医药,2005,27(4):295-296. 被引量:8
  • 6吴健平.女性吸毒者性病、HIV检测及分析[J].中国药物滥用防治杂志,2006,12(1):40-41. 被引量:7

二级参考文献29

  • 1王英,陈澜燕,张红漫,李慧英.HIV/AIDS流行控制中的社会性别分析[J].中国艾滋病性病,2004,10(3):172-174. 被引量:21
  • 2楼超华,沈燕,高尔生,涂晓雯.不同特征未婚流动人口性相关行为的发生状况[J].生殖与避孕,2005,25(12):738-744. 被引量:19
  • 3吴健平.女性吸毒者性病、HIV检测及分析[J].中国药物滥用防治杂志,2006,12(1):40-41. 被引量:7
  • 4赵晶,张致平,陈鸿珊,陈湘红,张兴权.黄芩甙元及其苄基衍生物的制备与抗人免疫缺陷病毒实验研究[J].药学学报,1997,32(2):140-143. 被引量:43
  • 5Wood E, Hogg RS, Yip B, et al. Effect of medication adherence on survival of HIV-infected adults who start highly active antiretroviral therapy when the CD4^+ cell count is 0. 2000 to 0.350 × 10^9 cells/L. Ann Intern Med, 2003,139:810-816.
  • 6Reinke R, Steffen NR, Robinson WE Jr. Natural selection results in conservation of HIV-1 integrase activity despite sequence variability. AIDS,2001,15:823.
  • 7Wai JS,Egbertson MS,Payne LS,et al.4-Aryl-2,4-dioxobutanoic acid inhibitors of HIV-1 Integrase and viral replication in cells. J Med Chem,2000,43:4923.
  • 8Kwon HC, Jung CM, Shin CG, et al. A new caffeoy lquinic acid from aster scaber and its inhibitory activity against human immunodeficiency virus-1(HIV-1) integrase. Chem Pharm Bull (Tokyo),2000,48:1796.
  • 9Kim SN, Lee JY, Kim HJ, et al. Synthesis and HIV-1 integrase inhibitory activities of caffeoyl glucosides. Bioorg Med Chem Lett,2000,10:1879.
  • 10Rusnati M, Urbinati C, Caputo A, et al. Pentosan polysulfate as an inhibitor of extracellular HIV-1 Tat. J Biol Chem,2001,276:22420.

共引文献19

同被引文献110

引证文献9

二级引证文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部